Vilon (Lys–Glu) is a synthetic dipeptide bioregulator and the shortest peptide with demonstrated biological activity. It modulates chromatin structure, stimulates thymocyte proliferation and gene expression, supports immune function, and shows anti-aging, regenerative, and anti-carcinogenic effects in preclinical models.[1]
Research Applications
1. Immune Function and Thymocyte Activity
Research shows Vilon stimulates thymocyte proliferation, upregulates markers such as CD5, and normalizes lymphocyte counts after immunosuppression.[4] It also supports regenerative activity in splenic and intestinal tissues.[4]
2. Anti-Aging and Lifespan Studies
In aged murine models, Vilon increased lifespan, improved physical endurance, and reduced spontaneous tumor incidence. Long-term administration showed no toxic effects, suggesting value as a tool in geroprotective research.[5]
3. Cancer Research
Vilon has been studied for its ability to reduce preneoplastic and neoplastic changes in experimental carcinogenesis.[6] In elderly colorectal cancer patients, adjunctive use improved two-year survival rates and lowered postoperative complications.[7]
4. Gastrointestinal and Organ Protection
Animal studies demonstrate Vilon enhances enzyme activity in the GI tract, improves nutrient absorption (glucose, glycine), and strengthens barrier function.⁸ It also modulates TGF-β1 in kidneys, supports hemostasis, and influences gene expression in cardiac tissue.[9]
Reconstitution and dosing
Vilon is typical reconstituted with Bacteriostatic water in various concentrations, usually in 10mg/ml. Vilon is typically dosed at 2mg per day for 20 days and this protocol is followed 2-3 times per year for immune system modulation and anti-aging.
For our free Peptide Calculator CLICK HERE
Referenced Citations
- Core Peptides – Vilon peptide research overview
- ResearchGate – Immunomodulating effects of Vilon and its analogue
- PubMed – Vilon-induced chromatin reactivation in lymphocytes
- Core Peptides – Vilon and thymocyte proliferation studies
- Umbrella Labs – Vilon peptide and anti-aging research
- Biotech Peptides – Vilon peptide and cancer cell studies
- PubMed – Clinical use of Vilon in elderly colorectal cancer patients
- Biotech Peptides – Vilon and gastrointestinal function in aging
- Biotech Peptides – Vilon effects on kidney, heart, and hemostasis